Breaking News Instant updates and real-time market news.

TEVA

Teva

$24.14

-0.1 (-0.41%)

13:55
07/10/18
07/10
13:55
07/10/18
13:55

Teva put volume heavy and directionally bearish

Bearish flow noted in Teva with 22,529 puts trading, or 3x expected. Most active are Sep-18 19 puts and Sep-18 18 puts, with total volume in those strikes near 18,600 contracts. The Put/Call Ratio is 2.61, while ATM IV is up over 1 point on the day. Earnings are expected on August 2nd.

  • 10

    Sep

  • 16

    Sep

TEVA Teva
$24.14

-0.1 (-0.41%)

06/18/18
WELS
06/18/18
UPGRADE
Target $23
WELS
Market Perform
Wells Fargo upgrades Teva to Market Perform after CEO meeting
Wells Fargo analyst David Maris upgraded Teva Pharmaceutical to Market Perform from Underperform and raised his price target for the shares to $23 from $18. The analyst had a "positive meeting" with Teva's CEO Kundefinedre Schultz and CFO Mike McClellan in Israel. Claims by investors that the new CEO is exactly what Teva needs seem to be well-founded, Maris tells investors in a research note. He thinks the "stage seems to be well set for a good narrative in the near-term." Maris also believes that consensus earnings estimates for Teva are too low. As such, the analyst does not see the stock underperforming in the near-term. Maris, however, maintains his caution on the longer-term generic industry margin risks.
06/18/18
06/18/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Francesca's (FRAN) upgraded to Buy from Neutral at B. Riley FBR with analyst Susan Anderson saying she has increased confidence in the company's turnaround following meetings with management. 2. Chevron (CVX) upgraded to Outperform from Market Perform at Raymond James with analyst Pavel Molchanov saying Chevron offers relatively more leverage than most peers to higher oil prices, which should reach cyclical highs over the next 6 to 12 months, while low WTI exposure maximizes earnings and free cash flow generation. 3. Trovagene (TROV) upgraded to Buy from Hold at Maxim with analyst Jason McCarthy citing the positive news from the company's lead drug candidate PCM-075 as well as its completion of a capital raise. 4. RBS (RBS) upgraded to Buy from Hold at Investec. 5. Teva (TEVA) upgraded to Market Perform from Underperform at Wells Fargo with analyst David Maris citing a "positive meeting" with Teva's CEO Kundefinedre Schultz and CFO Mike McClellan in Israel. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/25/18
GSCO
06/25/18
NO CHANGE
Target $28
GSCO
Buy
Teva price target raised to $28 from $25 at Goldman Sachs
Goldman analyst Jami Rubin raised Buy rated Teva's price target to $28 from $25 following meetings with management last week. The analyst said there has been a "stark shift" by interim management from being fairly reactionary and directionless to now being a company led by leaders who are "action-oriented" with a rapid and clear path to recovery. Rubin said the discussions focused on progress on price cuts, deleveraging, stabilization of the US generics business, specialty opportunities, and the next chapter of growth expected in 2020. The analyst believes guidance is likely to be revised higher as Copaxone has show to be more durable despite generic competition and US generics have stabilized and guidance still assumes ProAir competition this year. Further, Rubin sees upside potential from Austedo and Fremanezumab that could drive EBITDA upside and cash flow for faster debt repayment.
06/27/18
SBSH
06/27/18
NO CHANGE
SBSH
Buy
Teva added to CIti's US Focus List with 'favorable' risk-reward profile
Citi analyst Liav Abraham added Teva to his US Focus List, telling investors in a research note that he continues to see a "favorable" risk-reward profile and that the stock benefits from the most clear and material upside to estimates among the stocks in his coverage universe. He views earnings upside as the most material driver of stock price performance for the specialty pharma sector over the near to medium term, "especially against a backdrop of fundamentals that appear to have stabilized." Looking ahead, Abraham sees a guidance raise along with Q2 earnings.

TODAY'S FREE FLY STORIES

BV

BrightView

$21.95

0.14 (0.64%)

07:32
07/23/18
07/23
07:32
07/23/18
07:32
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTR

Nutrien

$52.43

0.43 (0.83%)

07:31
07/23/18
07/23
07:31
07/23/18
07:31
Hot Stocks
Nutrien seels equity state in Arab Potash Company »

Nutrien announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRX

Amneal Pharmaceuticals

$18.52

0.03 (0.16%)

07:31
07/23/18
07/23
07:31
07/23/18
07:31
Hot Stocks
Amneal receives FDA approval on ANDA for Potassium Chloride solution »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

FTSV

Forty Seven

$15.80

0.1 (0.64%)

07:31
07/23/18
07/23
07:31
07/23/18
07:31
Initiation
Forty Seven initiated  »

Forty Seven initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VFC

VF Corp.

$92.95

3.74 (4.19%)

, EXPE

Expedia

$125.50

-2.34 (-1.83%)

07:30
07/23/18
07/23
07:30
07/23/18
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

VFC

VF Corp.

$92.95

3.74 (4.19%)

EXPE

Expedia

$125.50

-2.34 (-1.83%)

PVG

Pretium Resources

$8.37

0.115 (1.39%)

TSN

Tyson Foods

$64.14

-0.76 (-1.17%)

SN

Sanchez Energy

$4.68

-0.14 (-2.90%)

NYCB

New York Community Bancorp

$11.41

-0.025 (-0.22%)

AN

AutoNation

$48.59

-0.75 (-1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 01

    Aug

  • 07

    Aug

  • 28

    Oct

BJ

BJ's Wholesale

$25.90

0.23 (0.90%)

07:29
07/23/18
07/23
07:29
07/23/18
07:29
Initiation
BJ's Wholesale initiated  »

BJ's Wholesale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIX

Wix.com

$104.35

-0.3 (-0.29%)

07:29
07/23/18
07/23
07:29
07/23/18
07:29
Recommendations
Wix.com analyst commentary  »

Wix.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 05

    Sep

  • 06

    Sep

FOXA

21st Century Fox

$46.01

-0.54 (-1.16%)

07:29
07/23/18
07/23
07:29
07/23/18
07:29
Conference/Events
21st Century Fox to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

SNAP

Snap

$13.27

-0.155 (-1.16%)

, SQ

Square

$70.41

0.11 (0.16%)

07:28
07/23/18
07/23
07:28
07/23/18
07:28
Periodicals
Snap to shutdown Snapcash, end partnership with Square, TechCrunch reports »

Snap (SNAP) will end its…

SNAP

Snap

$13.27

-0.155 (-1.16%)

SQ

Square

$70.41

0.11 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 07

    Aug

  • 15

    Aug

  • 16

    Aug

EVER

EverQuote

$17.99

0.43 (2.45%)

07:28
07/23/18
07/23
07:28
07/23/18
07:28
Initiation
EverQuote initiated  »

EverQuote initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

VFC

VF Corp.

$92.95

3.74 (4.19%)

07:27
07/23/18
07/23
07:27
07/23/18
07:27
Recommendations
VF Corp. analyst commentary  »

VF Corp. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$182.65

0.49 (0.27%)

, P

Pandora

$8.20

0.005 (0.06%)

07:27
07/23/18
07/23
07:27
07/23/18
07:27
Initiation
Spotify, Pandora initiated  »

Spotify initiated with a…

SPOT

Spotify

$182.65

0.49 (0.27%)

P

Pandora

$8.20

0.005 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 13

    Aug

  • 14

    Aug

SHOP

Shopify

$171.72

0.04 (0.02%)

07:27
07/23/18
07/23
07:27
07/23/18
07:27
Recommendations
Shopify analyst commentary  »

Shopify price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

BIIB

Biogen

$358.72

0.55 (0.15%)

07:26
07/23/18
07/23
07:26
07/23/18
07:26
Recommendations
Biogen analyst commentary  »

Biogen price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

07:25
07/23/18
07/23
07:25
07/23/18
07:25
General news
FX Update: The Dollar recovered losses »

FX Update: The Dollar…

GDDY

GoDaddy

$78.49

0.25 (0.32%)

07:24
07/23/18
07/23
07:24
07/23/18
07:24
Recommendations
GoDaddy analyst commentary  »

GoDaddy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

EVER

EverQuote

$17.99

0.43 (2.45%)

07:23
07/23/18
07/23
07:23
07/23/18
07:23
Initiation
EverQuote initiated  »

EverQuote initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

WCG

WellCare

$256.13

0.545 (0.21%)

07:22
07/23/18
07/23
07:22
07/23/18
07:22
Initiation
WellCare initiated  »

WellCare initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

MOH

Molina Healthcare

$106.16

0.64 (0.61%)

07:20
07/23/18
07/23
07:20
07/23/18
07:20
Initiation
Molina Healthcare initiated  »

Molina Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 21

    Aug

07:20
07/23/18
07/23
07:20
07/23/18
07:20
General news
Treasury Market Outlook: Treasury yields have dipped lower »

Treasury Market Outlook:…

CNC

Centene

$135.45

0.175 (0.13%)

07:19
07/23/18
07/23
07:19
07/23/18
07:19
Initiation
Centene initiated  »

Centene initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 10

    Aug

  • 23

    Oct

  • 14

    Dec

OMER

Omeros

$19.63

-0.42 (-2.09%)

07:19
07/23/18
07/23
07:19
07/23/18
07:19
Hot Stocks
Omeros initiates sales of Omidria in Europe, satisfies 'sunset clause' »

Omeros announced initial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOVE

Lovesac

$20.84

0.07 (0.34%)

07:19
07/23/18
07/23
07:19
07/23/18
07:19
Initiation
Lovesac initiated  »

Lovesac initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BJ

BJ's Wholesale

$25.90

0.23 (0.90%)

07:17
07/23/18
07/23
07:17
07/23/18
07:17
Initiation
BJ's Wholesale initiated  »

BJ's Wholesale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOX

21st Century Fox

$45.69

-0.5 (-1.08%)

07:16
07/23/18
07/23
07:16
07/23/18
07:16
Conference/Events
21st Century Fox to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.